{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:55:41Z","timestamp":1791424541914,"version":"4.3.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,5,26]],"date-time":"2010-05-26T00:00:00Z","timestamp":1274832000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Uncomplicated lower urinary tract infections (UTI) are usually treated with antibiotics. However, there is little evidence for alternative therapeutic options.<\/jats:p>\n                    <jats:p>This pilot study was set out 1) to make a rough estimate of the equivalence of ibuprofen and ciprofloxacin for uncomplicated urinary tract infection with regard to symptom resolution, and 2) to demonstrate the feasibility of a double-blind, randomized controlled drug trial in German general practices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a double-blind, randomized controlled pilot trial in 29 German general practices. Eighty otherwise healthy women aged 18 to 85 years, presenting with at least one of the main UTI symptoms dysuria and frequency and without any complicating factors, were randomly assigned to receive either ibuprofen 3 \u00d7 400 mg oral or ciprofloxacin 2 \u00d7 250 mg (+1 placebo) oral, both for three days.<\/jats:p>\n                    <jats:p>Intensity of main symptoms - dysuria, frequency, low abdominal pain - was recorded at inclusion and after 4, 7 and 28 days, scoring each symptom from 0 (none) to 4 (very strong). The primary endpoint was symptom resolution on Day 4. Secondary outcomes were the burden of symptoms on Days 4 and 7 (based on the sum score of all symptoms), symptom resolution on Day 7 and frequency of relapses. Equivalence margins for symptom burden on Day 4 were pre-specified as +\/- 0.5 sum score points. Data analysis was done by intention to treat and per protocol. Randomization was carried out on patient level by computer programme in blocks of six.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seventy-nine patients were analyzed (ibuprofen n = 40, ciprofloxacin n = 39). On Day 4, 21\/36 (58.3%) of patients in the ibuprofen-group were symptom-free versus 17\/33 (51.5%) in the ciprofloxacin-group. On Day 4, ibuprofen patients reported fewer symptoms in terms of total sum score (1; SD 1,42) than ciprofloxacin patients (1,3; SD 1,9), difference -0,33 (95% CI (-1,13 to +0,47)), PP (per protocol) analysis. During Days 0 and 9, 12\/36 (33%) of patients in the ibuprofen-group received secondary antibiotic treatment due to ongoing or worsening symptoms, compared to 6\/33 (18%) in the ciprofloxacin-group (non significant). A total of 58 non-serious adverse events were reported, 32 in the ibuprofen group versus 26 in the ciprofloxacin group (non significant).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results support the assumption of non-inferiority of ibuprofen compared to ciprofloxacin for treatment of symptomatic uncomplicated UTI, but need confirmation by further trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>Trial registration number: ISRCTN00470468<\/jats:p>\n                    <jats:p>\n                      See Commentary\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.biomedcentral.com\/1471-2296\/11\/42\" ext-link-type=\"uri\">http:\/\/www.biomedcentral.com\/1471-2296\/11\/42<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/1741-7015-8-30","type":"journal-article","created":{"date-parts":[[2010,6,23]],"date-time":"2010-06-23T14:14:44Z","timestamp":1277302484000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":148,"title":["Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection? - Results of a randomized controlled pilot trial"],"prefix":"10.1186","volume":"8","author":[{"given":"Jutta","family":"Bleidorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ildik\u00f3","family":"G\u00e1gyor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M","family":"Kochen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Wegscheider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Hummers-Pradier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,26]]},"reference":[{"key":"289_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0891-5520(03)00005-9","volume":"17","author":"B Foxman","year":"2003","unstructured":"Foxman B, Brown P: Epidemiology of urinary tract infections transmission and risk factors, incidence, and costs. Infect Dis Clin North Am. 2003, 17: 227-241. 10.1016\/S0891-5520(03)00005-9.","journal-title":"Infect Dis Clin North Am"},{"key":"289_CR2","volume-title":"SIGN publication no 88 Edinburgh","author":"Scottish Intercollegiate Guidelines Network (SIGN)","year":"2006","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN): Management of suspected bacterial urinary tract infection in adults. A national clinical guideline. SIGN publication no 88 Edinburgh. 2006"},{"key":"289_CR3","first-page":"35","volume":"76","author":"E Hummers-Pradier","year":"2000","unstructured":"Hummers-Pradier E, Kochen MM: Dysuria. DEGAM-guideline No. 1 (in German). Z Allg Med. 2000, 76: 35-48.","journal-title":"Z Allg Med"},{"key":"289_CR4","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1503\/cmaj.081587","volume":"180","author":"L Nicolle","year":"2009","unstructured":"Nicolle L, Conly JM, MacDonald N: Embracing ecology to limit antimicrobial resistance. CMAJ. 2009, 180: 371-372.","journal-title":"CMAJ"},{"key":"289_CR5","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1503\/cmaj.080626","volume":"180","author":"DM Patrick","year":"2009","unstructured":"Patrick DM, Hutchinson J: Antibiotic use and population ecology how you can reduce your \"resistance footprint\". CMAJ. 2009, 180: 416-421.","journal-title":"CMAJ"},{"key":"289_CR6","first-page":"785","volume":"57","author":"CC Butler","year":"2007","unstructured":"Butler CC, Dunstan F, Heginbothom M, Mason B, Roberts Z, Hillier S, Howe R, Palmer S, Howard A: Containing antibiotic resistance decreased antibiotic-resistant coliform urinary tract infections with reduction in antibiotic prescribing by general practices. Br J Gen Pract. 2007, 57: 785-792.","journal-title":"Br J Gen Pract"},{"key":"289_CR7","first-page":"241","volume":"41","author":"JV Jolleys","year":"1991","unstructured":"Jolleys JV: Factors associated with regular episodes of dysuria among women in one rural general practice. Br J Gen Pract. 1991, 41: 241-243.","journal-title":"Br J Gen Pract"},{"key":"289_CR8","first-page":"335","volume":"40","author":"JV Jolleys","year":"1990","unstructured":"Jolleys JV: The reported prevalence of urinary symptoms in women in one rural general practice. Br J Gen Pract. 1990, 40: 335-337.","journal-title":"Br J Gen Pract"},{"key":"289_CR9","first-page":"729","volume":"52","author":"TC Christiaens","year":"2002","unstructured":"Christiaens TC, De Meyere M, Verschraegen G, Peersman W, Heytens S, De Maeseneer JM: Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women. Br J Gen Pract. 2002, 52: 729-734.","journal-title":"Br J Gen Pract"},{"key":"289_CR10","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1080\/00365540410019642","volume":"36","author":"SA Ferry","year":"2004","unstructured":"Ferry SA, Holm SE, Stenlund H, Lundholm R, Monsen TJ: The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study. Scand J Infect Dis. 2004, 36: 296-301. 10.1080\/00365540410019642.","journal-title":"Scand J Infect Dis"},{"issue":"Suppl A","key":"289_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/jac\/33.suppl_A.147","volume":"33","author":"W Brumfitt","year":"1994","unstructured":"Brumfitt W, Hamilton-Miller JM: Consensus viewpoint on management of urinary infections. J Antimicrob Chemother. 1994, 33 (Suppl A): 147-153.","journal-title":"J Antimicrob Chemother"},{"key":"289_CR12","first-page":"708","volume":"52","author":"L Leibovici","year":"2002","unstructured":"Leibovici L: Antibiotic treatment for cystitis. Br J Gen Pract. 2002, 52: 708-710.","journal-title":"Br J Gen Pract"},{"key":"289_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/fampra\/cmh720","volume":"22","author":"E Hummers-Pradier","year":"2005","unstructured":"Hummers-Pradier E, Ohse AM, Koch M, Heizmann WR, Kochen MM: Management of urinary tract infections in female general practice patients. Fam Pract. 2005, 22: 71-77. 10.1093\/fampra\/cmh720.","journal-title":"Fam Pract"},{"key":"289_CR14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1155\/2005\/385768","volume":"16","author":"L Nicolle","year":"2005","unstructured":"Nicolle L, AMMI Canada Guidelines Committee*: Complicated urinary tract infection in adults. Can J Infect Dis Med Microbiol. 2005, 16: 349-360.","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"289_CR15","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1001\/archinte.167.3.253","volume":"167","author":"R Meiland","year":"2007","unstructured":"Meiland R, Stolk RP, Geerlings SE, Peeters PH, Grobbee DE, Coenjaerts FE, Brouwer EC, Hoepelman AI: Association between Escherichia coli bacteriuria and renal function in women long-term follow-up. Arch Intern Med. 2007, 167: 253-257. 10.1001\/archinte.167.3.253.","journal-title":"Arch Intern Med"},{"key":"289_CR16","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1080\/00365540410021009","volume":"37","author":"E Hummers-Pradier","year":"2005","unstructured":"Hummers-Pradier E, Koch M, Ohse AM, Heizmann WR, Kochen MM: Antibiotic resistance of urinary pathogens in female general practice patients. Scand J Infect Dis. 2005, 37: 256-261. 10.1080\/00365540410021009.","journal-title":"Scand J Infect Dis"},{"key":"289_CR17","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1001\/jama.293.8.949","volume":"293","author":"TM Hooton","year":"2005","unstructured":"Hooton TM, Scholes D, Gupta K, Stapleton AE, Roberts PL, Stamm WE: Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women a randomized trial. JAMA. 2005, 293: 949-955. 10.1001\/jama.293.8.949.","journal-title":"JAMA"},{"key":"289_CR18","first-page":"CD003597","volume":"3","author":"V Rafalsky","year":"2006","unstructured":"Rafalsky V, Andreeva I, Rjabkova E: Quinolones for uncomplicated acute cystitis in women. Cochrane Database Syst Rev. 2006, 3: CD003597.","journal-title":"Cochrane Database Syst Rev"},{"key":"289_CR19","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1093\/jac\/dkl368","volume":"58","author":"CA McNulty","year":"2006","unstructured":"McNulty CA, Richards J, Livermore DM, Little P, Charlett A, Freeman E, Harvey I, Thomas M: Clinical relevance of laboratory-reported antibiotic resistance in acute uncomplicated urinary tract infection in primary care. J Antimicrob Chemother. 2006, 58: 1000-1008. 10.1093\/jac\/dkl368.","journal-title":"J Antimicrob Chemother"},{"key":"289_CR20","volume-title":"EAU guidelines for the management of urinary and male genital tract infections","author":"EAU (European Association of Urology)","year":"2006","unstructured":"EAU (European Association of Urology): EAU guidelines for the management of urinary and male genital tract infections. 2006, European Association of Urology, [http:\/\/www.uroweb.org\/fileadmin\/user_upload\/Guidelines\/The%20Management%20of%20Male%20Urinary%20and%20Genital%20Tract%20Infections.pdf]"},{"key":"289_CR21","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1471-2296-9-64","volume":"9","author":"BJ Knottnerus","year":"2008","unstructured":"Knottnerus BJ, Bindels PJ, Geerlings SE, Moll van Charante EP, ter Riet G: Optimizing the diagnostic work-up of acute uncomplicated urinary tract infections. BMC Fam Pract. 2008, 9: 64-10.1186\/1471-2296-9-64.","journal-title":"BMC Fam Pract"},{"key":"289_CR22","first-page":"309","volume":"50","author":"LF Verest","year":"2000","unstructured":"Verest LF, van Esch WM, van Ree JW, Stobberingh EE: Management of acute uncomplicated urinary tract infections in general practice in the south of The Netherlands. Br J Gen Pract. 2000, 50: 309-310.","journal-title":"Br J Gen Pract"},{"key":"289_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta13190","volume":"13","author":"P Little","year":"2009","unstructured":"Little P, Turner S, Rumsby K, Warner G, Moore M, Lowes J, Smith H, Hawke C, Turner D, Leydon G, Arscott A, Mullee M: Dipsticks and diagnostic algorithms in urinary tract infection development and validation, randomised trial, economic analysis, observational cohort and qualitative study. Health Technol Assess. 2009, 13: 1-96.","journal-title":"Health Technol Assess"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-8-30.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1741-7015-8-30\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-8-30","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-8-30.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:36:31Z","timestamp":1630456591000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/1741-7015-8-30"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,26]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["289"],"URL":"https:\/\/doi.org\/10.1186\/1741-7015-8-30","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.3438957.3133054","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.3438957.8536084","asserted-by":"object"}]},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,26]]},"assertion":[{"value":"9 April 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"30"}}